Literature DB >> 22622327

Extracellular matrix constituents interfere with Newcastle disease virus spread in solid tissue and diminish its potential oncolytic activity.

Barak Yaacov1, Itay Lazar2, Shay Tayeb1, Sivan Frank2, Uzi Izhar3, Michal Lotem4, Riki Perlman2, Dina Ben-Yehuda2, Zichria Zakay-Rones1, Amos Panet1.   

Abstract

Advanced melanoma cells, characterized by resistance to chemotherapy, have been shown to be highly sensitive to oncolysis by Newcastle disease virus (NDV). In the present study, we investigated the capacity of NDV to specifically infect and spread into solid tissues of human melanoma and lung carcinoma, in vivo and ex vivo. For this purpose a new model of SCID-beige mice implanted with human melanoma was developed. Surprisingly, the replication competent NDV-MTH and the attenuated, single-cycle replication NDV-HUJ strains, demonstrated a similar oncolytic activity in the melanoma-implanted mice. Further, ex vivo analysis, using organ cultures derived from the melanoma tissues indicated a limited spread of the two NDV strains in the tissue. Extracellular matrix (ECM) molecules, notably heparin sulfate and collagen, were found to limit viral spread in the tissue. This observation was validated with yet another solid tumour of human lung carcinoma. Taken together, the results indicate that the ECM acts as a barrier to virus spread within solid tumour tissues and that this restriction must be overcome to achieve effective oncolysis with NDV.

Entities:  

Mesh:

Year:  2012        PMID: 22622327     DOI: 10.1099/vir.0.043281-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

Review 1.  Oncolytic viruses: overcoming translational challenges.

Authors:  Jordi Martinez-Quintanilla; Ivan Seah; Melissa Chua; Khalid Shah
Journal:  J Clin Invest       Date:  2019-03-04       Impact factor: 14.808

Review 2.  Oncolytic virotherapy for urological cancers.

Authors:  Zahid Delwar; Kaixin Zhang; Paul S Rennie; William Jia
Journal:  Nat Rev Urol       Date:  2016-05-24       Impact factor: 14.432

3.  Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.

Authors:  Or Alfi; Arkadi Yakirevitch; Ori Wald; Ori Wandel; Uzi Izhar; Esther Oiknine-Djian; Yuval Nevo; Sharona Elgavish; Elad Dagan; Ory Madgar; Gilad Feinmesser; Eli Pikarsky; Michal Bronstein; Olesya Vorontsov; Wayne Jonas; John Ives; Joan Walter; Zichria Zakay-Rones; Menachem Oberbaum; Amos Panet; Dana G Wolf
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

Review 4.  Viruses in cancer treatment.

Authors:  R Alemany
Journal:  Clin Transl Oncol       Date:  2012-11-10       Impact factor: 3.340

Review 5.  Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition.

Authors:  Janaina Fernandes
Journal:  Biomark Cancer       Date:  2016-07-28

Review 6.  Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer.

Authors:  Anwen Howells; Giulia Marelli; Nicholas R Lemoine; Yaohe Wang
Journal:  Front Oncol       Date:  2017-09-08       Impact factor: 6.244

Review 7.  Extracellular Matrix in Plants and Animals: Hooks and Locks for Viruses.

Authors:  Livia Stavolone; Vincenzo Lionetti
Journal:  Front Microbiol       Date:  2017-09-12       Impact factor: 5.640

8.  Mechanisms of foot-and-mouth disease virus tropism inferred from differential tissue gene expression.

Authors:  James J Zhu; Jonathan Arzt; Michael C Puckette; George R Smoliga; Juan M Pacheco; Luis L Rodriguez
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

9.  Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells.

Authors:  Ke Jiang; Yingchun Li; Qiumin Zhu; Jiansheng Xu; Yupeng Wang; Wuguo Deng; Quentin Liu; Guirong Zhang; Songshu Meng
Journal:  BMC Cancer       Date:  2014-07-30       Impact factor: 4.430

Review 10.  Therapeutic potential of oncolytic Newcastle disease virus: a critical review.

Authors:  Shay Tayeb; Zichria Zakay-Rones; Amos Panet
Journal:  Oncolytic Virother       Date:  2015-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.